| Apria Healthcare Llc | |
| 7370 Eastgate Road, Suites 140 And 145, Henderson, Nevada 89011 | |
| (702) 736-4466 |
| Name | Apria Healthcare Llc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 7370 Eastgate Road, Suites 140 And 145, Henderson, Nevada 89011 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (702) 736-4466 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Women who undergo treatment for screening-detected cervical intraepithelial neoplasia are more than four times more likely to develop cervical cancer than women with normal smear tests, research suggests.
Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).
Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.
Two of the world's leading universities are joining forces to combine neuroscience and engineering in order to alleviate human suffering caused by such neurological disabilities as paralysis and deafness. Scientists, engineers, and clinicians at Harvard Medical School (HMS) and Ecole Polytechnique F-d-rale de Lausanne (EPFL) will collaborate on six pioneering neuroengineering projects made possible thanks to a $3.6 million grant from the Bertarelli Foundation.
› Verified 3 days ago
| NPI Number | 1740395565 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7370 Eastgate Rd Ste 140&145, Henderson, NV 89011 |
| Phone Number | 702-736-4466 |
News Archive
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Women who undergo treatment for screening-detected cervical intraepithelial neoplasia are more than four times more likely to develop cervical cancer than women with normal smear tests, research suggests.
Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).
Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.
Two of the world's leading universities are joining forces to combine neuroscience and engineering in order to alleviate human suffering caused by such neurological disabilities as paralysis and deafness. Scientists, engineers, and clinicians at Harvard Medical School (HMS) and Ecole Polytechnique F-d-rale de Lausanne (EPFL) will collaborate on six pioneering neuroengineering projects made possible thanks to a $3.6 million grant from the Bertarelli Foundation.
› Verified 3 days ago
| NPI Number | 1801965017 |
| Organization Name | APRIA HEALTHCARE, INC. |
| Type | Home Infusion Therapy Pharmacy |
| Address | 3955 W Mesa Vista Ave, Suite 1, Las Vegas, NV 89118 |
| Phone Number | 702-736-4466 |
News Archive
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Women who undergo treatment for screening-detected cervical intraepithelial neoplasia are more than four times more likely to develop cervical cancer than women with normal smear tests, research suggests.
Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).
Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.
Two of the world's leading universities are joining forces to combine neuroscience and engineering in order to alleviate human suffering caused by such neurological disabilities as paralysis and deafness. Scientists, engineers, and clinicians at Harvard Medical School (HMS) and Ecole Polytechnique F-d-rale de Lausanne (EPFL) will collaborate on six pioneering neuroengineering projects made possible thanks to a $3.6 million grant from the Bertarelli Foundation.
› Verified 3 days ago
News Archive
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Women who undergo treatment for screening-detected cervical intraepithelial neoplasia are more than four times more likely to develop cervical cancer than women with normal smear tests, research suggests.
Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).
Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.
Two of the world's leading universities are joining forces to combine neuroscience and engineering in order to alleviate human suffering caused by such neurological disabilities as paralysis and deafness. Scientists, engineers, and clinicians at Harvard Medical School (HMS) and Ecole Polytechnique F-d-rale de Lausanne (EPFL) will collaborate on six pioneering neuroengineering projects made possible thanks to a $3.6 million grant from the Bertarelli Foundation.
› Verified 3 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7370 Eastgate Road, Henderson, Nevada 89011 Phone: (702) 736-4466 | |
Cvs Pharmacy #08822 Type: Pharmacy Location: 2594 Wigwam Pkwy, Henderson, Nevada 89074 Phone: (702) 260-0291 | |
Cvs Pharmacy #08787 Type: Pharmacy Location: 1551 W Sunset Rd, Henderson, Nevada 89014 Phone: (702) 433-6536 | |
Cvs Pharmacy #05811 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1990 W Sunset Rd, Henderson, Nevada 89014 Phone: (702) 454-0671 | |
Cvs Pharmacy #06717 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 60 N Valle Verde Dr, Henderson, Nevada 89074 Phone: (702) 898-0036 |